Post-Poliosyndrome Treated With Intravenous Immunoglobulin (IvIg)

Status Completed

Clinical Trial Summary

Inflammatory cytokines in the cerebrospinal fluid may contribute to the new muscle weakness, fatigue and pain experienced by patients with post-polio syndrome. Intravenousimmunoglobulin (IvIg) reduces this inflammation. The purpose of this study is to investigate the clinical effect of IvIg in post-polio syndrome.

Clinical Trial Description

Post-polio syndrome (PPS) is characterised by new muscle weakness, pain, and fatigue several years after the attack of acute polio. This leads to increased disability, and up to now only supportive therapy is available.

Patients with PPS lose more motor neurons than expected and surviving neurons fail to maintain neurogenic supply to enlarged motor units. New data report an increased level of inflammatory cytokines in the cerebrospinal fluid (CSF). Immune modulating therapy like IvIg could be an option and this pilot study is the first to investigate the clinical effect of IvIg in PPS. In addition, levels of cytokines in CSF and serum before and after treatment will be investigated. ;

Study Design

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double-Blind, Primary Purpose: Treatment

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT00231439
Study type	Interventional
Source	Haukeland University Hospital
Contact
Status	Completed
Phase	Phase 2/Phase 3
Start date	August 2003
Completion date	July 2004

View Details

See also
Status	Clinical Trial	Phase
Terminated	`NCT02176863` - Study of the Efficacy and Safety of Immune Globulin Intravenous (Human) Flebogamma® 5% DIF in Patients With Post-polio Syndrome	Phase 2/Phase 3
Active, not recruiting	`NCT03561623` - Spinal Cord Gray Matter Imaging in Post Polio Syndrome
Completed	`NCT02815878` - Enhance Wellness for Individuals With Long-Term Physical Disabilities	N/A
Recruiting	`NCT05644522` - Nomad P-KAFO Study	N/A
Completed	`NCT02801071` - L-Citrulline in Patients With Post-Polio Syndrome	Phase 3
Completed	`NCT03064711` - Activity and Fatigue of the Respiratory Muscles and Pulmonary Characteristics in Post-Polio Patients	N/A
Completed	`NCT01537575` - Intravenous Immunoglobulins for Post-Polio Syndrome	Phase 3
Active, not recruiting	`NCT02089880` - Comparing Functional Outcomes in Individuals Using Micro-processor Controlled Orthosis Versus Stance Control Orthosis	N/A
Completed	`NCT01402570` - Glutathione and Health With Post-Polio Syndrome	N/A